» Articles » PMID: 32730972

Postoperative Magnetic Resonance Imaging After Surgery of Brain Metastases: Analysis of Extent of Resection and Potential Risk Factors for Incomplete Resection

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2020 Jul 31
PMID 32730972
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Extent of resection (EOR) constitutes a crucial factor for patient prognosis in surgery of brain metastases (BMs). According to early studies using postoperative magnetic resonance imaging (MRI), an unexpected residual tumor was not uncommon. Knowledge of potential risk factors for incomplete BM resection would be of major importance to optimize surgical strategies. The aim of this study was to evaluate EOR in a large cohort and analyze potential risk factors for incomplete BM resection.

Methods: Patients with BM resection and available postoperative MRI were included. Intraoperative estimation of EOR by the neurosurgeon was noted. Additionally, EOR was determined by postoperative MRI. Potential risk factors for incomplete resection were investigated.

Results: There were 145 patients with 163 BMs included. According to postoperative MRI, complete resection was achieved in 103 (63%) BMs, and resection was incomplete in 44 (27%) BMs. Postoperative MRI detected unexpected residual tumor in 32 (25%) BMs, and a misjudgment of the EOR by the neurosurgeon was found in 29% of cases. Regarding risk factors for incomplete resection, preoperative tumor volume was significantly larger in incompletely resected BMs compared with completely resected BMs (P = 0.011). All other analyzed risk factors had no significant influence on EOR.

Conclusions: Our data indicate that postoperative MRI is able to detect a high portion of unexpected residual tumors after surgery of BMs. Preoperative tumor volume in particular represents an important risk factor for incomplete resection, and hence neurosurgeons should pay special attention to avoid residual tumor tissue.

Citing Articles

Comparison of anatomical-based vs. nTMS-based risk stratification model for predicting postoperative motor outcome and extent of resection in brain tumor surgery.

Ivren M, Grittner U, Khakhar R, Belotti F, Schneider H, Poser P Neuroimage Clin. 2023; 38:103436.

PMID: 37236052 PMC: 10232884. DOI: 10.1016/j.nicl.2023.103436.


Neurosurgical Interventions for Cerebral Metastases of Solid Tumors.

Thon N, Karschnia P, von Baumgarten L, Niyazi M, Steinbach J, Tonn J Dtsch Arztebl Int. 2023; 120(10):162-169.

PMID: 36650742 PMC: 10201951. DOI: 10.3238/arztebl.m2022.0410.


Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.

Imber B, Young R, Beal K, Reiner A, Giantini-Larsen A, Krebs S J Neurooncol. 2022; 159(3):609-618.

PMID: 35896906 PMC: 9328626. DOI: 10.1007/s11060-022-04101-9.


MRI-Based Risk Assessment for Incomplete Resection of Brain Metastases.

Rosenstock T, Poser P, Wasilewski D, Bauknecht H, Grittner U, Picht T Front Oncol. 2022; 12:873175.

PMID: 35651793 PMC: 9149256. DOI: 10.3389/fonc.2022.873175.